Kura Oncology (KURA) Total Non-Current Liabilities: 2024-2025
Historic Total Non-Current Liabilities for Kura Oncology (KURA) over the last 2 years, with Sep 2025 value amounting to $403.9 million.
- Kura Oncology's Total Non-Current Liabilities rose 653.54% to $403.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $403.9 million, marking a year-over-year increase of 653.54%. This contributed to the annual value of $344.7 million for FY2024, which is N/A change from last year.
- Per Kura Oncology's latest filing, its Total Non-Current Liabilities stood at $403.9 million for Q3 2025, which was up 7.88% from $374.3 million recorded in Q2 2025.
- Kura Oncology's 5-year Total Non-Current Liabilities high stood at $403.9 million for Q3 2025, and its period low was $47.9 million during Q2 2024.
- In the last 2 years, Kura Oncology's Total Non-Current Liabilities had a median value of $344.7 million in 2024 and averaged $235.6 million.
- Data for Kura Oncology's Total Non-Current Liabilities shows a peak YoY spiked of 687.96% (in 2025) over the last 5 years.
- Over the past 2 years, Kura Oncology's Total Non-Current Liabilities (Quarterly) stood at $344.7 million in 2024, then surged by 653.54% to $403.9 million in 2025.
- Its last three reported values are $403.9 million in Q3 2025, $374.3 million for Q2 2025, and $377.2 million during Q1 2025.